[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.191.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1935

ORAL ADMINISTRATION OF POTASSIUM BISMUTH TARTRATE IN TREATMENT OF SYPHILIS

Author Affiliations

Professor of Medicine, Temple University, and Director of the Research Institute of Cutaneous Medicine PHILADELPHIA

From the Research Institute of Cutaneous Medicine and the Department of Medicine, Temple University.

Arch Derm Syphilol. 1935;31(1):9-14. doi:10.1001/archderm.1935.01460190012002
Abstract

The therapeutic possibilities of bismuth preparations by oral administration in the treatment of syphilis have not received the attention they deserve. By this route of administration I have found that water-soluble potassium bismuth tartrate-D. R. L. is less toxic than the mercurial compounds generally employed and much more spirocheticidal.

It is true, however, that oral medication in the treatment of syphilis has gradually fallen into disrepute during the past twenty years because it fosters the under-treatment of the disease, but, as Schamberg and Wright1 stated in relation to the oral administration of mercury: "The time has not yet arrived when the method of treating syphilis by ingestion can be placed upon the shelf of discarded therapeutic methods and thus be allowed to lapse into total oblivion." They quote Pusey (1922) that:

under ordinary methods of treatment with mercury by the mouth where treatment was carried out persistently, recurrences, except

×